Engineered Escherichia Coli Produces C14-Enriched Lipid Adjuvant Homologs in Bioreactor Batches
Researchers engineered Escherichia coli to produce C14-enriched monophosphorylated lipid A homologs that demonstrated in vitro murine and human TLR4 agonist ...

